Current Edition

News

Dotmatics and RockStep partner on digitalised in vivo drug discovery

Dotmatics Ltd, an Insightful Science company that provides scientific informatics software, has announced a partnership with RockStep, a developer of software tools ...
Continue Reading →
News

Enamine expands collaboration with UCSF to explore synthetically feasible chemical space

Enamine Ltd., a chemical research organization and producer of novel building blocks and screening libraries, has today announced that it has expanded its collaborat...
Continue Reading →
News

SYGNIS AG Installs Scalable Production Capability for Lightning-Link Antibody Conjugation Technology

SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today...
Continue Reading →
News

Drug discovery must change to urgently address global health needs: Oxford researchers call for a new Pharmaceutical Commons

A new paper published today by the Oxford Martin School at the University of Oxford calls for ‘open science’ approaches to drug discovery and offers ways forward tha...
Continue Reading →
News

Horizon Discovery’s Dharmacon introduces Edit-R CRISPRa reagent platform for genome-wide CRISPR activation

Horizon Discovery, a global leader in gene editing and gene modulation technologies, today announced the launch of its reagent platform for CRISPR activation (CRISPR...
Continue Reading →
Straightforward or Challenging? Why It Matters Where You Place DM&PK Studies
Drug Discovery, Development & Delivery v4i3

Straightforward or Challenging? Why It Matters Where You Place DM&PK Studies

Medical research has been a major underlying factor leading to the dramatic reduction in overall morbidity and mortality in the 20th century. In his book, The De...
Continue Reading →
Clinically-relevant in vitro and in vivo Oncology Models for Drug Discovery
Clinical Research v4i3

Clinically-relevant in vitro and in vivo Oncology Models for Drug Discovery

The success rate in predicting clinical efficacy of anti-cancer modalities using current xenograft models has been reported to be only 30-40%. Standard xenograft...
Continue Reading →
Reduce Costs and Gain Expertise by Outsourcing your Cell Culture and Cryostorage
Drug Discovery, Development & Delivery v4i3

Reduce Costs and Gain Expertise by Outsourcing your Cell Culture and Cryostorage

Cell culture has evolved over more than a century into a core technique that is central to a diverse range of research and clinical applications. These range fro...
Continue Reading →
Novel Factories for Novel Vaccines
Drug Discovery, Development & Delivery v4i3

Novel Factories for Novel Vaccines

Vaccination is considered one of the most successful strategies for fighting infectious diseases, an area where there still remain significant unmet medical need...
Continue Reading →